Alnylam Pharmaceuticals Inc (ALNY.O)

ALNY.O on Nasdaq

65.59USD
5 Feb 2016
Change (% chg)

$-1.92 (-2.84%)
Prev Close
$67.51
Open
$67.22
Day's High
$68.01
Day's Low
$63.70
Volume
1,326,204
Avg. Vol
974,612
52-wk High
$140.00
52-wk Low
$61.09

ALNY.O

Chart for ALNY.O

About

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the research and development of therapeutics based on its ribonucleic acid interference (RNAi). The Company’s pipeline focuses in three strategic therapeutic areas (STArs): Genetic Medicines, with a pipeline of RNAi therapeutics for the... (more)

Overall

Beta: 2.56
Market Cap(Mil.): $5,557.81
Shares Outstanding(Mil.): 84.74
Dividend: --
Yield (%): --

Financials

  ALNY.O Industry Sector
P/E (TTM): -- 36.97 38.72
EPS (TTM): -2.65 -- --
ROI: -19.12 6.90 14.47
ROE: -19.83 8.97 15.40
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks